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Objectives: Cerebrovascular stroke is a main cause of lasting disability in older 
age, and initial stroke severity has been established as a main determinant for the 
degree of functional loss. In this study, we searched for other predictors of func-
tional outcome in a cohort of stroke patients participating in an early supported 
discharge randomised controlled trial.
Methods: Thirty candidate variables related either to premorbid history or to the 
acute stroke were examined by ordered logistic regression in 229 stroke patients. 
Dependent variables were modified Rankin Scale (mRS) at 6 months and mRS 
change from baseline to 6 months.
Results: For mRS at 6 months, Barthel Index at stable baseline post- stroke was 
the main predictor, with sex, age, previous cerebrovascular disease, previous periph-
eral artery disease and the necessity for tube feeding in the acute phase also 
contributing to the final model. For mRS change, only age and previous cerebro-
vascular disease were significant predictors. Prestroke subjective health complaints 
added significantly to all final models concurrently with sex losing its predictive 
power.
Conclusions: Initial stroke severity was the main predictor of functional outcome. 
Subjective health complaints score was a potent predictor for both outcome and 
improvement from baseline to 6 months and at the same time ameliorated the 
predictive impact of sex. The poorer functional prognosis for women after stroke 
may therefore be related to their higher load of subjective health complaints rather 
than to their sex itself. Treating these complaints may possibly improve the func-
tional prognosis.
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O R I G I N A L  A R T I C L E
Subjective health complaints predict functional outcome six 
months after stroke
H. Hofstad1,2 | H. Næss3,4,5 | B. E. B. Gjelsvik2,6 | G. E. Eide7,8 | J. S. Skouen1,2
1  | INTRODUCTION
Cerebrovascular stroke is today the second most common cause of 
death and the third most common cause of disability- adjusted life years 
lost.1 The number of patients living with disabilities following stroke 
must be expected to rise further in the future due to demographic 
changes with increasing number of aged people.2 The degree of dis-
ability and reduced functional capacity after stroke is aetiologically 
multifactorial. The severity of the initial neurologic affection has been 
established as a main determinant, and some other variables as sex, 
age, previous cerebrovascular disease and previous peripheral artery 
disease are frequently reported to be important predictors,3–9 but 
more specific knowledge about other possible predictive factors is 
needed in order to optimise stroke outcome.
We have recently conducted a randomised controlled trial (the 
ESD Stroke Bergen study) exploring the results of three different 
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rehabilitation schemes after stroke, where two of the randomisation 
groups were treated within the concept of early supported discharge 
(ESD) and one group which received treatment as usual served as 
controls.10 The main results of this study have been published previ-
ously.11 The aim of the present study was to identify possible predic-
tors for (1) the patients’ functional level 6 months after stroke (eval-
uated by mRS12 at 6 months), and (2) the change in functional level 
from stable baseline (1 week post- stroke, or at discharge if discharged 
earlier) to 6 months after stroke (evaluated by change in mRS).
2  | PATIENTS AND METHODS
2.1 | Study design and patients
The ESD Stroke Bergen study recruited participants between 8 
December 2008 and 20 December 2011, among patients admitted 
with confirmed acute cerebrovascular stroke (infarctions and cerebral 
haemorrhages, but excluding subarachnoid haemorrhage) to the 
stroke unit at the Department of Neurology, Haukeland University 
Hospital in Bergen, Norway.10,11 The inclusion criteria for the study 
were wide, and the majority of acute stroke patients living in 
Bergen and admitted to the stroke unit were included, finally 
reaching 306 participants. The study was approved by the Western 
Norway Regional Committee for Medical Research Ethics.
Two hundred and twenty- nine of the 306 included patients were 
scored for the primary outcome mRS at 6 months, giving a follow- up 
rate of 74.8%. Main reasons for dropout were patients experiencing full 
recovery, being in a nursing home or not wanting to travel to the hos-
pital for testing. These 229 patients constituted the study population 
in the present substudy, which thus has a prospective cohort design.
2.2 | Independent variables
Most baseline data were routinely collected during the stay in the 
stroke unit and prospectively registered in a database (the Bergen 
NORSTROKE Registry).13 Some of the data (randomisation group, 
subjective health complaints, Mini Mental State Examination [MMSE] 
score at baseline)14 were collected specifically as part of the ESD 
Stroke Bergen study. Altogether, this comprised demographic infor-
mation, previous medical history and clinical information (examina-
tions and scorings, treatment and complications) from the acute 
phase in the stroke unit. The data hence fell into two different 
categories: either related to the patient’s life and medical history 
prior to stroke or to the stroke itself and the stay in the stroke 
unit. We selected 16 and 13 relevant variables considered to be 
of potential relevance for the functional outcome from each of 
these groups. In addition, we added the randomisation group in 
the main RCT study as a last variable, thereby ending up with 30 
different possible predictors in the study.
Twenty of the variables were dichotomous, while some were ordi-
nal (previous smoking, estimated mRS before the stroke, Barthel Index 
at stable baseline, National Institutes of Health Stroke Scale [NIHSS] at 
stable baseline), some continuous (age, subjective health complaints pre-
stroke, MMSE score at baseline) and some categorical (location of lesion, 
TOAST- classification,4 randomisation group).
NIHSS at stable baseline was scored according to a Norwegian 34- 
point version.15
Subjective health complaints was investigated using the Subjective 
Health Complaint Inventory described by Eriksen et al.16 This inventory 
consists of 29 items concerning subjective somatic and psychological 
complaints experienced during the previous 30 days. Factor analy-
sis has indicated five different inventory subscales: musculoskeletal 
pain (headache, neck pain, upper back pain, low back pain, arm pain, 
shoulder pain, migraine and leg pain during physical activity), pseud-
oneurology (extra heartbeats, heat flushes, sleep problems, tiredness, 
dizziness, anxiety and sadness/depression), gastrointestinal problems 
(heartburn, stomach discomfort, ulcer/non- ulcer dyspepsia, stom-
ach pain, gas discomfort, diarrhoea and obstipation), allergy (asthma, 
breathing difficulties, eczema, allergy and chest pain) and flu (cold/flu 
and coughing).16 The items are scored on a 4- point Likert scale (0–3; 
not at all/a little/some/serious). In this study, the period immediately 
before the stroke was explicitly defined as the report period and the 
scorings were obtained during the first week after admittance to the 
stroke unit. Patients with communication difficulties due to severe 
aphasia were not included in the subjective health complaints scoring.
Three of the variables (subjective health complaints, estimated mRS 
before the stroke and MMSE score at baseline) were introduced during 
the study period, leading to missing values for these variables in a cer-
tain number of the included patients.
2.3 | Dependent variables
Two different dependent variables were used in the study; mRS12 
6 months after stroke and change in mRS from baseline to 6 months. 
mRS evaluates the patient’s functional competency in seven levels 
(0–6) where scores from 0 to 2 signify independency, 3–5 varying 
degrees of dependency and 6 death of the patient. mRS change 
signifies the difference between 6 months and baseline values. 
mRS is a nonparametric ordinal variable, and mRS change was 
therefore considered likewise.
2.4 | Statistical analysis
Groups of patients completing the study and dropouts were com-
pared for all selected variables using appropriate statistical tests 
(Pearson’s exact chi- square test, t- test, Mann–Whitney U- test, 
Fisher’s exact test). Significance level was set at 0.05 for all 
analyses.
Predictors for the outcomes mRS at 6 months and mRS change 
score from baseline to 6 months were explored by ordered logistic 
regression. All 30 variables were used in unadjusted regression. For 
the adjusted regression analyses, 24 of the 30 selected variables were 
used, leaving out six which were available only in a limited number of 
patients. Final models were elaborated by stepwise backward regres-
sion from the full model, leaving out the least significant predictor at 
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each step and finishing when all included variables added significantly 
to the model. Age and sex were by choice kept in all analyses, and 
the final models therefore contained these two variables in addition to 
remaining variables adding significantly to the model. The last six vari-
ables were finally added to the final models one at a time, to explore 
their possible effects. Also in the regression analyses, a significance 
level of 0.05 was set for all comparisons.
The statistical programme package Stata/SE 13.1 for Windows 
(StataCorp LP, College Station, TX, USA) was used for all data analyses.
3  | RESULTS
3.1 | Modified Rankin Scale scores and change 
scores
The mean (SD) mRS score at baseline for all 229 participants was 
2.66 (1.23), whereas at 6 months, the mean score was 2.52 (1.50). 
Mean change score from baseline to 6 months was −0.15 (1.21).
3.2 | Analyses of predictors at baseline
Comparison of all 30 variables between the groups of patients 
completing the study and dropouts (30 comparisons) showed no 
significant differences except for baseline total Barthel Index score 
and estimated mRS before the stroke (Table 1). Mean Barthel score 
was higher (better) in the dropouts (83.4) vs patients completing 
the study (75.3) (P=.008). However, patients who died between 
baseline and 6 months (n=16) were included among the completers 
(with a mRS=6), and excluding them from the analyses reduced 
the difference to 83.4 vs 78.3 (P=.038). Also, estimated prestroke 
mRS was better in the dropouts compared to completers (P=.037).
3.3 | Analyses of predictors for mRS at 6 months
The results of the regression analyses for mRS at 6 months are 
given in Table 2, providing unadjusted results for all 30 variables, 
fully adjusted results for the 24 variables with only a few (0 to 
6)  missing observations, as well as the final model after stepwise 
backward regression. In the unadjusted model, many variables were 
significant predictors, but in the fully adjusted model only sex, 
Barthel Index at stable baseline and tube feeding necessary in acute 
phase were. In the final model sex, age, previous cerebrovascular 
disease, previous peripheral artery disease, Barthel Index at stable 
baseline and tube feeding necessary in acute phase were significant 
predictors for mRS at 6 months.
3.4 | Analyses of predictors for mRS change from 
stable baseline to 6 months
The same procedure was repeated with mRS change score from 
stable baseline to 6 months as dependent variable. Unadjusted 
regression (Table 3) showed significance for eight variables (sex, 
age, previous cerebrovascular disease, previous peripheral artery disease, 
tube feeding necessary in acute phase, leukoaraiosis on CT or MRI, 
subjective health complaints and estimated mRS before the stroke), 
whereas in the fully adjusted model only two (sex and tube feeding 
necessary in acute phase) were significant predictors. In the final 
model, sex and previous cerebrovascular disease showed as significant 
negative predictors.
3.5 | Subjective health complaints as predictor for 
mRS at 6 months and mRS change from stable baseline 
to 6 months
The variable subjective health complaints was registered in a limited 
number of the patients and was therefore not included in the 
fully adjusted and final regression models. As subjective health 
complaints, however, was a highly significant predictor in all 
unadjusted analyses, the effect of this variable was explored by 
adding it to the final models elaborated. The findings are given 
in Table 4.
The predictive power of subjective health complaints was retained 
in both modified final models, at about the same significance level 
as in the unadjusted analyses. Concurrently, the predictive power 
of sex was completely eliminated. Post hoc we therefore also anal-
ysed subjective health complaints in men and women separately and 
found a significantly higher score in women than in men (0.44 vs 0.28, 
P=.005). In addition, all variables were compared between the patient 
groups with (n=121) and without (n=108) obtained subjective health 
complaints score to detect possible discrepancies between them. We 
found no statistically significant differences except for urinary incon-
tinence which was more common in patients without subjective health 
complaints scored (P=.024).
4  | DISCUSSION
Potential predictors for functional outcome 6 months after acute 
stroke have been systematically analysed using ordered logistic 
regression in 229 patients, recruited as participants in a randomised 
controlled trial comparing different rehabilitation schemes. The 
original patient cohort comprised 306 patients, but 77 of these 
dropped out before the 6 month scoring of the dependent vari-
able mRS. Comparison of the completers and the drop- outs showed 
no definite difference except for a better function evaluated by 
Barthel Index in the dropouts, but this was to a large extent 
caused by patients dying before 6 months being included among 
completers. We therefore consider our results to be generalizable 
to the full stroke cohort.
As could be expected, the strongest predictor for absolute func-
tional level at 6 months was the patients’ functional level at stable 
baseline, expressed by Barthel Index score. Previous cerebrovascular 
disease and peripheral artery disease were significant negative predic-
tors. Patients needing tube feeding obviously constitute a group with 
low general function, explaining the negative prediction.
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The variables studied were selected from availability and clinical 
purposefulness. Variables with more than six missing observations 
were not included in the fully adjusted analyses and primary final mod-
els to keep a high number of patients as basis for the results. Some of 
these variables were significant predictors in the unadjusted analyses, 
but only one of them (subjective health complaints) remained a highly 
significant predictor also when added to the elaborated final models.
As mRS change from baseline to 6 months constitutes the degree 
of functional improvement or deterioration after acute stroke, signif-
icant predictors signify a definite influence on the patient’s degree of 
recovery after the stroke. Such predictors were much sparser than pre-
dictors for the absolute functional level after stroke, but tube feeding 
in the acute phase was consistently a significant negative predictor 
also for this outcome. Barthel Index in the stable acute phase had no 
TABLE  1 Premorbid and stroke- related variables in 306 ESD Stroke Bergen study patients; all patients and split between 229 completers 
and 77 dropouts
Variable All patients (N=306) Completers (n=229) Dropouts (n=77) P- valuea
Premorbid variables:
Sex; males/females (% male) 169/137 (55.2) 122/107 (53.3) 47/30 (61.0) .236
Age, years; mean 72.24 72.19 72.39 .910
Previous cerebrovascular disease; yes/no (% yes)* 62/238 (20.8) 44/181 (19.6) 18/57 (24.0) .410
Previous coronary disease; yes/no (% yes) 71/235 (23.2) 55/174 (24.0) 16/61 (20.8) .560
Previous peripheral artery disease; yes/no (% yes) 20/286 (6.5) 13/216 (5.7) 7/70 (9.1) .294
Previous hypertension; yes/no (% yes) 177/129 (57.8) 132/97 (57.6) 45/32 (58.4) .902
Previous diabetes; yes/no (% yes)* 46/258 (15.1) 32/196 (14.0) 14/62 (18.4) .355
Previous atrial fibrillation, paroxystic; yes/no (% yes) 29/277 (9.5) 21/208 (9.2) 8/69 (10.4) .752
Previous atrial fibrillation, chronic; yes/no (% yes) 27/279 (8.8) 19/210 (8.3) 8/69 (10.4) .575
Previous smoking; never/previous/current* 128/102/65 97/82/44 31/20/21 .436
Living with partner; yes/no (% yes) 169/137 (55.2) 129/100 (56.3) 40/37 (51.9) .503
In work before the stroke; yes/no (% yes)* 63/242 (20.7) 48/181 (21.0) 15/61 (19.7) .819
Subjective health complaints prestroke; mean item score#* 0.37 0.36 0.40 .479
Estimated mRS before the stroke; 0/1/2/3/4* 150/8/21/9/1 111/7/19/8/1 39/1/2/1/0 .037
Previous migraine; yes/no (% yes)* 49/186 (20.9) 42/137 (23.5) 7/49 (12.5) .078
Previous depression, yes/no (% yes)* 48/190 (20.2) 34/144 (19.1) 14/46 (23.3) .480
Stroke- related variables:
Barthel Index at stable baseline; mean* 77.3 75.3 83.4 .008
NIHSS at stable baseline; mean* 4.0 4.2 3.3 .228
Type of stroke; infarction/haemorrhage (% infarction) 270/36 (88.2) 202/27 (88.2) 68/9 (88.3) .981
Thrombolysis performed; yes/no (% yes) 44/262 (14.4) 35/194 (15.3) 9/68 (11.7) .437
Tube feeding necessary in acute phase; yes/no (% yes) 26/280 (8.5) 23/206 (10.0) 3/74 (3.9) .094
Urinary retention in acute phase; yes/no (% yes) 105/201 (34.3) 82/147 (35.8) 23/54 (29.9) .342
Urinary incontinence in acute phase; yes/no (% yes) 57/249 (18.6) 48/181 (21.0) 9/68 (11.7) .071
Pneumonia in acute phase; yes/no (% yes) 34/272 (11.1) 29/200 (12.7) 5/72 (6.5) .136
Urinary tract infection in acute phase; yes/no (% yes) 41/265 (13.4) 32/197 (14.0) 9/68 (11.7) .611
Leukoaraiosis on CT or MRI; yes/no (% yes) 159/147 (52.0) 123/106 (53.7) 36/41 (46.8) .290
Location of lesion; n (%) .678
Lacunar syndrome 75 (24.5) 57 (24.9) 18 (23.4)
Total anterior circulation syndrome 37 (12.1) 30 (13.1) 7 (9.1)
Partial anterior circulation syndrome 130 (42.5) 97 (42.4) 33 (42.9)
Posterior circulation syndrome 64 (20.9) 45 (19.7) 19 (24.7)
TOAST- classification (infarctions only); n (%) .253
Atherosclerosis 28 (10.4) 22 (10.9) 6 (8.8)
Cardiac embolic 99 (36.7) 69 (34.2) 30 (44.1)
Microangiopathy 38 (14.1) 30 (14.9) 8 (11.8)
Others 3 (1.1) 1 (0.5) 2 (2.9)
Unknown 102 (37.8) 80 (39.6) 22 (32.4)
MMSE score at baseline; mean* 23.7 24.0 22.5 .205
Randomisation group; n (%) .075
Day unit treatment 103 (33.7) 81 (35.4) 22 (28.6)
Home treatment 104 (34.0) 82 (35.8) 22 (28.6)
Control 99 (32.4) 66 (28.8) 33 (42.9)
ESD, early supported discharge; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; CT, Computerised Tomography; MR, 
Magnetic Resonance Imaging; TOAST, Trial of Org 10172 in Acute Stroke Treatment4; MMSE, Mini Mental State Examination.
aComparison between completers and dropouts, statistical tests: χ2- test, t- test, Mann–Whitney U- test or Fisher’s exact test as appropriate; *some data are 
missing; #Likert scale 0–3. P- values ≤.05 indicated in bold.
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TABLE  2 Unadjusted, fully adjusted and final models after ordered logistic regression of mRS at 6 months of potential predictors in 229 ESD 
Stroke Bergen study patients
Predictor
Unadjusted model




P-valuen OR 95% CI P- value OR 95% CI OR 95% CI
Premorbid variables:
Sex (female vs male) 229 2.00 (1.25, 3.20) .004 2.28 (1.27, 4.09) .006 2.04 (1.23, 3.39) .006
Age per 10 years 229 1.71 (1.40, 2.09) <.001 1.33 (0.94, 1.88) .103 1.32 (1.06, 1.64) .012
Previous cerebrovascular 
disease
225 2.27 (1.25, 4.13) .007 1.82 (0.85, 3.90) .124 2.24 (1.20, 4.16) .011
Previous coronary disease 229 1.22 (0.72, 2.08) .454 1.21 (0.61, 2.40) .577
Previous peripheral artery 
disease
229 3.64 (1.08, 12.3) .037 3.06 (0.80, 11.73) .100 5.89 (1.73, 
20.00)
.004
Previous hypertension 229 1.92 (1.20, 3.08) .007 1.18 (0.66, 2.09) .578
Previous diabetes 228 1.40 (0.73, 2.70) .313 1.14 (0.48, 2.72) .765
Previous atrial fibrillation, 
paroxystic
229 1.24 (0.56, 2.74) .597 0.43 (0.16, 1.12) .084
Previous atrial fibrillation, 
chronic
229 2.27 (0.89, 5.74) .085 1.97 (0.57, 6.84) .285
Previous smoking 223 1.02 (0.75, 1.39) .903 1.27 (0.87, 1.86) .215
Living with partner 229 0.57 (0.36, 0.92) .021 0.80 (0.44, 1.43) .447
In work before the stroke 229 0.30 (0.17, 0.52) <.001 1.30 (0.55, 3.08) .549
Stroke- related variables:
Barthel Index at stable 
baseline per 5 points
227 0.74 (0.70, 0.78) <.001 0.78 (0.70, 0.85) <.001 0.76 (0.71, 0.81) <.001
NIHSS at stable baseline 227 1.28 (1.20, 1.36) <.001 1.11 (0.98, 1.26) .094
Haemorrhage vs infarction 229 1.26 (0.87, 1.84) .227 0.89 (0.56, 1.42) .627
Thrombolysis performed 229 0.95 (0.50, 1.82) .883 0.54 (0.25, 1.15) 0.108
Tube feeding necessary in 
acute phase
229 16.4 (6.91, 39.0) <.001 3.81 (1.10, 13.17) .032 2.61 (1.02, 6.72) .044
Urinary retention in acute 
phase
229 2.10 (1.29, 3.43) .003 0.78 (0.42, 1.44) .423
Urinary incontinence in 
acute phase
229 6.53 (3.54, 12.1) <.001 1.03 (0.48, 2.25) .933
Pneumonia in acute phase 229 8.53 (4.07, 17.9) <.001 2.02 (0.73, 5.61) .176
Urinary tract infection in 
acute phase
229 3.80 (1.95, 7.37) <.001 1.68 (0.71, 3.96) .237
Leukoaraiosis on CT or 
MRI
229 2.61 (1.62, 4.21) <.001 1.82 (0.97, 3.40) .061
Location of lesion 229 <.001 .055
Lacunar syndrome 57 0.18 (0.08, 0.41) <.001 1.58 (0.49, 5.07)
Total anterior circulation 
syndrome
30 1 (reference) 1 (reference)
Partial anterior 
circulation syndrome
97 0.25 (0.12, 0.51) <.001 3.22 (1.04, 9.98)
Posterior circulation 
syndrome
45 0.18 (0.08, 0.43) <.001 3.33 (0.95, 11.6)
Randomisation group 229 .408 .137
Day unit treatment 81 0.69 (0.38, 1.23) .204 0.51 (0.25, 1.02)
Home treatment 82 0.73 (0.41, 1.30) .291 0.80 (0.40, 1.59)




Atherosclerosis 22 0.81 (0.35, 1.92) .639
Cardiac embolic 69 1 (reference)
Microangiopathy 30 0.32 (0.14, 0.70) .004
Others 1 0.44 (0.02, 8.27) .586
Unknown 80 0.68 (0.38, 1.22) .197
(Continues)
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Predictor
Unadjusted model




P-valuen OR 95% CI P- value OR 95% CI OR 95% CI
Subjective health complaints 121 5.25 (1.77, 15.55) .003
Estimated mRS before the 
stroke
146 2.37 (1.72, 3.27) <.001
Previous migraine 179 0.60 (0.33, 1.11) .102
Previous depression 178 1.08 (0.55, 2.09) .825
MMSE score at baseline 104 0.87 (0.81, 0.93) <.001
ESD, early supported discharge; mRS, modified Rankin Scale; OR, Odds Ratio; CI, Confidence Interval; LR- test, Likelihood ratio test; NIHSS, National 
Institutes of Health Stroke Scale; CT, Computerised Tomography; MRI, Magnetic Resonance Imaging; TOAST, Trial of Org 10172 in Acute Stroke 
Treatment4; MMSE, Mini Mental State Examination. P- values ≤.05 indicated in bold.
T A B L E  2  (Continued)
TABLE  3 Unadjusted, fully adjusted and final models after ordered logistic regression of mRS change from baseline to 6 months of potential 
predictors in 229 ESD Stroke Bergen study patients
Predictor
Unadjusted model




P- valuen OR 95% CI P-value OR 95% CI OR 95% CI
Premorbid variables:
Sex (female vs male) 229 1.79 (1.11, 2.88) .016 2.09 (1.17, 3.74) .013 1.69 (1.03, 2.76) .037
Age per 10 years 229 1.26 (1.04, 1.52) .016 1.30 (0.94, 1.82) .117 1.19 (0.08, 1.45) .080
Previous cerebrovascular 
disease
225 2.45 (1.35, 4.45) .003 2.03 (0.97, 4.27) .060 2.39 (1.31, 4.38) .005
Previous coronary disease 229 1.44 (0.83, 2.51) .193 1.77 (0.91, 3.43) .091
Previous peripheral artery 
disease
229 3.29 (1.15, 9.37) .026 1.88 (0.57, 6.24) .305
Previous hypertension 229 1.42 (0.88, 2.29) .147 1.33 (0.75, 2.33) .328
Previous diabetes 228 1.00 (0.50, 1.98) .989 0.66 (0.28, 1.53) .333
Previous atrial fibrillation, 
paroxystic
229 0.70 (0.31, 1.62) .410 0.42 (0.16, 1.10) .076
Previous atrial fibrillation, 
chronic
229 2.31 (0.96, 5.60) .063 2.20 (0.73, 6.66) .163
Previous smoking 223 1.08 (0.79, 1.48) .637 1.33 (0.91, 1.95) .142
Living with partner 229 0.76 (0.47, 1.21) .246 0.92 (0.53, 1.62) .785
In work before the stroke 229 0.72 (0.41, 1.26) .246 1.65 (0.70, 3.90) .250
Stroke- related variables:
Barthel Index at stable 
baseline per 5 points
227 1.00 (0.96, 1.04) .927 1.05 (0.97, 1.14) .255
NIHSS at stable baseline 227 0.98 (0.93, 1.03) .428 1.01 (0.90, 1.14) .819
Haemorrhage vs 
infarction
229 0.75 (0.51, 1.11) .147 0.78 (0.50, 1.21) .259
Thrombolysis performed 229 0.61 (0.32, 1.19) .146 0.73 (0.34, 1.59) .433
Tube feeding necessary in 
acute phase
229 2.67 (1.21, 5.89) .015 4.60 (1.53, 13.82) .007
Urinary retention in acute 
phase
229 0.73 (0.45, 1.19) .203 0.69 (0.37, 1.27) .233
Urinary incontinence in 
acute phase
229 1.03 (0.59, 1.80) .927 1.05 (0.51, 2.15) .898
Pneumonia in acute phase 229 1.61 (0.78, 3.32) .201 2.31 (0.87, 6.14) .093
Urinary tract infection in 
acute phase
229 1.22 (0.64, 2.32) .547 1.15 (0.51, 2.60) .737
Leukoaraiosis on CT or  
MRI
229 1.66 (1.03, 2.68) .036 1.17 (0.64, 2.14) .611
Location of lesion 229 .342 .164
Lacunar syndrome 57 1.24 (0.55, 2.81) .606 1.51 (0.49, 4.63)
(Continues)
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significant influence on the patients’ improvement or deterioration, 
and neither had randomisation group in the ESD study.
The variables estimated mRS before the stroke (but retrospectively 
evaluated afterwards), subjective health complaints (also before the 
stroke, but scored shortly after the stroke) as well as MMSE were not 
collected from the beginning of the study and the number of obser-
vations is therefore markedly lower than for the other variables. 
They were significant predictors in the unadjusted analyses, but not 
included in the adjusted analyses as described above.
To explore their effects, these variables were added to the final 
models. Previous mRS and MMSE showed some significance, but this 
was not pursued further in this study. The by far strongest of the three 
variables was subjective health complaints score, being a strong pre-
dictor both for absolute functional level at 6 months (P=.003) and mRS 
change from baseline to 6 months (P<.001). To examine the gener-
alizability of these findings to the total patient group, we compared 
the other variables between the patients groups with and without 
subjective health complaints score obtained and found no difference 
between them. This indicates that the findings regarding subjective 
health complaints are generalizable to the full study patient group. 
The degree of reported subjective health complaints thus seems to be 
an important determinant for both improvement and functional level 
6 months after stroke.
Subjective health complaints have previously been reported to be 
frequent in patients with low back pain, thereby alluding to the psy-
chosomatic aspect of this condition.17 On a more general basis, a high 
level of subjective health complaints signifies increased risk of long 
term sickness absence from work.18
For reasons of principle, we included the variables sex and age in 
all analyses, but the results regarding these predictors were somewhat 
conflicting and difficult to interpret. A basic question, especially con-
cerning age, is whether the apparent associations are due to ageing 
itself or secondary to other causes. Regarding sex, previous research-
ers have generally reported a negative effect of female sex on func-
tional outcome.5,19–27 This is seen also in the present study (for details, 
see11). However, when corrected for subjective health complaints, the 
predictive value of sex disappeared completely, as seen in Table 4. 
In our study, subjective health complaints also are much more com-
mon in females than in males, and the poorer functional prognosis in 
females may therefore be related to their degree of subjective health 
complaints rather than to their sex alone. The women in our study 
were on average 6 years older than the males,11 but the significant 
relationship between subjective health complaints and functional out-
come still holds adjusted for age (results not shown).
This relationship between subjective health complaints and 
functional outcome after stroke has to our knowledge neither been 
Predictor
Unadjusted model




P- valuen OR 95% CI P-value OR 95% CI OR 95% CI
Total anterior 
circulation syndrome
30 1 (reference) 1 (reference)
Partial anterior 
circulation syndrome
97 1.80 (0.85, 3.82) .127 2.62 (0.88, 7.73)
Posterior circulation 
syndrome
45 1.76 (0.75, 4.13) .196 2.82 (0.85, 9.36)
Randomisation group 229 .523 .409
Day unit treatment 81 0.83 (0.46, 1.48) .523 0.67 (0.35, 1.31)
Home treatment 82 0.71 (0.39, 1.28) .257 0.66 (0.33, 1.30)




Atherosclerosis 22 0.86 (0.36, 2.06) .728
Cardiac embolic 69 1 (reference)
Microangiopathy 30 0.52 (0.24, 1.14) .102
Others 1 1.15 (0.05, 25.6) .930
Unknown 80 0.99 (0.55, 1.79) .980
Subjective health 
complaints
121 10.19 (3.10, 33.48) <.001
Estimated mRS before the 
stroke
146 1.55 (1.13, 2.11) .006
Previous migraine 179 0.70 (0.38, 1.29) .250
Previous depression 178 1.18 (0.62, 2.27) .611
MMSE score at baseline 104 0.98 (0.92, 1.05) .624
ESD, Early Supported Discharge; mRS, modified Rankin Scale; OR, Odds Ratio; CI, Confidence Interval; LR- test, Likelihood ratio test; NIHSS, National 
Institutes of Health Stroke Scale; CT, Computerised Tomography; MRI, Magnetic Resonance Imaging; TOAST, Trial of Org 10172 in Acute Stroke 
Treatment4; MMSE, Mini Mental State Examination. P- values ≤.05 indicated in bold.
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examined nor reported before, and we suggest that a higher burden of 
subjective health complaints may be a contributing explanation for the 
frequent finding of worse functional prognosis after stroke in women 
than in men.
Possible predictive factors for the functional outcome after stroke 
have been investigated in many previous studies.3–9,28,29 The most 
dominant finding is that the severity of neurological or functional 
disability immediately after the stroke has a major influence.3–9,28,29 
This has been demonstrated universally and it is also a main finding 
in our study. In addition higher age,3,5,8,9 female sex,5,19,21–27 prior 
cerebrovascular disease,3,5,8 peripheral artery disease,7 arm paresis,5 
diabetes,5,7 fever,5 TOAST- classification 4,28 and infarct location,5,6,28 
among others, have been reported to be negative predictors. The main 
results in our study thus are consistent with previous findings, empha-
sising especially stroke severity and prior cerebrovascular disease in 
addition to age and sex. The sex effect has by others been suggested 
to be secondary to other factors,20,22,24 and this is supported by our 
findings concerning subjective health complaints.
Factors predicting the degree of functional improvement from sta-
ble baseline to 6 months (mRS change score) were quite sparse in the 
present study. Only higher age and the amount of reported subjective 
health complaints were statistically significant in the final models, and 
subjective health complaints was by far the stronger predictor of the 
two. Unlike most other predictors subjective health complaints may be 
accessible for treatment and modification in the rehabilitation period, 
for example by cognitive therapy or education in more simple coping 
strategies, and this might contribute to a better functional outcome.
Depression might conceivably be one explanation for subjective 
health complaints being a negative predictor. Depression is however 
only one of 29 items of the Subjective Health Complaints Inventory 
and hence contributes only very modestly to the score. In addition, 
depression was one of the 30 independent variables explored in the 
study, but without significance in the univariate analyses.
The prospective design may be considered a strength of the study, 
whereas the number of missing data for some variables is an obvious lim-
itation. The patients scored for these variables were however selected 
only by their late recruitment to the study, and they should therefore be 
expected to constitute a random sample of the total study population. 
This assumption was confirmed by the comparative analysis.
In conclusion, the present study supports the previous general 
finding of stroke severity being a main predictor for post- stroke func-
tion. It also lends support to sex, age, previous cerebrovascular and 
peripheral artery disease as well as tube feeding in the acute phase 
as negative predictors. Importantly, however, the degree of prestroke 
subjective health complaints was found to be a potent negative pre-
dictor for functional outcome in general and possibly a main explana-
tion for the worse functional prognosis in female stroke patients. This 
predictor should be taken into account in future intervention studies 
and in the rehabilitation of stroke patients.
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